|
MRPS6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.194000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.274400E-01 |
| Normal-vs-Stage2 |
4.067000E-01 |
| Normal-vs-Stage3 |
2.586200E-01 |
| Normal-vs-Stage4 |
1.591000E-01 |
| Stage1-vs-Stage2 |
8.375400E-01 |
| Stage1-vs-Stage3 |
9.385600E-01 |
| Stage1-vs-Stage4 |
6.239600E-01 |
| Stage2-vs-Stage3 |
8.153000E-01 |
| Stage2-vs-Stage4 |
5.762400E-01 |
| Stage3-vs-Stage4 |
7.057200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.871400E-01 |
| Normal-vs-AfricanAmerican |
8.318200E-01 |
| Normal-vs-Asian |
2.253800E-01 |
| Caucasian-vs-AfricanAmerican |
4.843200E-01 |
| Caucasian-vs-Asian |
9.969800E-01 |
| AfricanAmerican-vs-Asian |
4.797000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.374560E-01 |
| Normal-vs-Female |
2.872200E-01 |
| Male-vs-Female |
4.608600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.031400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.548800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.207670E-02 |
| Normal-vs-Age(81-100Yrs) |
8.107400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.114400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.707800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.073200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.141700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.374400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.327600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.049900E-02 |
| Classical-VS-Follicular |
4.378400E-02 |
| Classical-VS-Other |
3.938600E-01 |
| Classical-VS-Normal |
5.386400E-01 |
| Tall-VS-Follicular |
8.232400E-01 |
| Tall-VS-Other |
9.393800E-01 |
| Tall-VS-Normal |
3.692200E-02 |
| Follicular-VS-Other |
8.806000E-01 |
| Follicular-VS-Normal |
4.052400E-02 |
| Other-VS-Normal |
2.199800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.878020E-01 |
| Normal-vs-N1 |
1.598080E-02 |
| N0-vs-N1 |
1.388570E-01 |
|
|
